transduced anti-CD33-ζ and anti-CD33-CD28-OX40-ζ CARs into CIK cells and found that the CD33 CAR enhanced the anti-leukemic functions of CIK cells against HL60 and KG-1a cell lines and primary AML blasts (123). This evidence concerns the gene CD33 and acute myeloid leukemia.